In the present study, we identified that RBM11 is especially expressed in ovarian cancer tissues, but not in normal ovary tissue, which demonstrates that RBM11 is a feasible target for drug design in future ovarian cancer treatment. The gene discussed is RBM11; the disease is ovarian carcinoma.